Poland – Pharmaceutical products – Supply of medicinal products from the group: Medicines available under the drug programme; Medicines used in chemotherapy for the full range of registered indications and intended uses and for an indication defined by a clinical condition; antineoplastic and immunomodulating medicines and non-specific immunoglobulins (according to the ATC classification) – from the list of 31 packages
Supply of medicinal products from the group: Medicines available under the drug programme; Medicines used in chemotherapy for the full range of registered indications and intended uses and for an indication defined by a clinical condition; antineoplastic
Opportunity description
Supply of medicinal products from the group: Medicines available under the drug programme; Medicines used in chemotherapy for the full range of registered indications and intended uses and for an indication defined by a clinical condition; antineoplastic and immunomodulating medicines and non-specific immunoglobulins (according to the ATC classification) – from the list of 31 packages vial 10 mg vial 500 mg vial 20 mg vial 10 mg/10 ml tablets 100 mg capsules 1 mg ampoule 5 mg/1 ml film-coated tablets 40 mg vial 100 mg vial 100 mcg/0,5 ml vial 200 mg, powder for concentrate for solution for infusion vial 100 mg, concentrate for solution for infusion vial 140 mg, powder for concentrate for solution for infusion pre-filled syringe 135 mcg/0,5ml soft capsules 150 mg film-coated tablets 500 mg film-coated tablets 100 mg vial 10 g/100ml vial 5 g/50ml vial 500 mg/10 ml vial 120 mg/1,7 ml vial 1800mg/15ml film-coated tablets 300 mg vial 2000 mg vial 350 mg film-coated tablets 20 mg or film-coated tablets 40 mg or film-coated tablets 60 mg film-coated tablets 200 mg, film-coated tablets 50 mg / film-coated tablets 200 mg, film-coated tablets 150 mg hard capsules, 300+0,5 mg vial 100 mg/6ml Procedure: open. Review the original TED notice for the complete requirement, lots, amendments and attachments.
Business details are available after sign in
Codes, capabilities, evidence, buyer details and marketplace actions are withheld from the public HTML and API response.